Mariana Ruiz, autor en Biblioteca Digital Médico Científica

Sistema de Actualización Médica, Heridas y Cicatrización. Fascículo #1.

Mariana Ruiz / 06/12/2022

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Autor: Fecha […]

Documento, Documento-Fibrosis Hepática

Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases.

Mariana Ruiz / 18/10/2022

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Autor: Fecha

Documento, Documento-Fibrosis Pulmonar

Role of pirfenidone in TGF‑β pathways and other inflammatory pathways in acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) infection: a theoretical perspective.

Mariana Ruiz / 18/10/2022

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Autor: Fecha

Documento, Documento-Fibrosis Hepática

Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease.

Mariana Ruiz / 22/08/2022

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Autor: Fecha

Documento, Documento-Fibrosis Pulmonar

Effects of low-dose pirfenidone on survival and lung function decline in patients with idiopathic pulmonary fibrosis (IPF): Results from a real-world study.

Mariana Ruiz / 22/08/2022

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Autor: Fecha

Documento, Documento-Fibrosis Hepática, Documento-Fibrosis Pulmonar

Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis.

Mariana Ruiz / 22/08/2022

Autor: Fecha de Publicación: Editorial:

Documento, Documento-Heridas y Ulceras

Topical Administration of Pirfenidone Increases Healing of Chronic Diabetic Foot Ulcers: A Randomized Crossover Study.

Mariana Ruiz / 22/08/2022

Autor: Fecha de Publicación: Editorial:

Documento, Documento-Heridas y Ulceras

Pirfenidone Accelerates Wound Healing in Chronic Diabetic Foot Ulcers: A Randomized, Double-Blind Controlled Trial.

Mariana Ruiz / 22/08/2022

Autor: Fecha de Publicación: Editorial:

Documento, Documento-Fibrosis Pulmonar

Post-COVID-19 Pulmonary Fibrosis.

Mariana Ruiz / 30/05/2022

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Autor: Fecha

Documento, Documento-Cicatrices

Pirfenidone increases the epithelialization rate of skin graft donor sites.

Mariana Ruiz / 05/05/2022

Autor: Fecha de Publicación: Editorial:

Documento, Documento-otros

Fibrosis — A Common Pathway to Organ Injury and Failure.

Mariana Ruiz / 05/05/2022

Autor: Fecha de Publicación: Editorial:

Documento, Documento-Fibrosis Hepática

Sustained Remission After Treatment Withdrawal in Autoimmune Hepatitis.

Mariana Ruiz / 05/05/2022

Autor: Fecha de Publicación: Editorial:

Biblioteca Digital Médico Científica 2.0

Nombre del autor:Mariana Ruiz

Sistema de Actualización Médica, Heridas y Cicatrización. Fascículo #1.

Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases.

Role of pirfenidone in TGF‑β pathways and other inflammatory pathways in acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) infection: a theoretical perspective.

Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease.

Effects of low-dose pirfenidone on survival and lung function decline in patients with idiopathic pulmonary fibrosis (IPF): Results from a real-world study.

Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis.

Topical Administration of Pirfenidone Increases Healing of Chronic Diabetic Foot Ulcers: A Randomized Crossover Study.

Pirfenidone Accelerates Wound Healing in Chronic Diabetic Foot Ulcers: A Randomized, Double-Blind Controlled Trial.

Post-COVID-19 Pulmonary Fibrosis.

Pirfenidone increases the epithelialization rate of skin graft donor sites.

Fibrosis — A Common Pathway to Organ Injury and Failure.

Sustained Remission After Treatment Withdrawal in Autoimmune Hepatitis.

Acceso para profesionales de la salud